Open Journal Systems

The Indian pharma iron market

Pooja Swaminathan

Abstract

This article briefly covers various diseses/ conditions where iron supplementation is required. World Health Organization consider anemia, resulting from iron deficieny as a serious global health probelm. Iron formulations are prescribed by various physicians and available in multiple formulations and in India various companies/ brands compete to improve their market share.

Keywords

anemia, iron deficiency, pharmaceuticals, brand

References

Babati, Babak (2020). Howson, Peter (ed.). Special Report: India COVID-19 Briefing. The Business Year. p. 10. ISBN 9781912498574. Retrieved 20 February 2021. Since the mid-1960s, India has made a name for itself as a manufacturing center for pharmaceuticals. By under[-]license manufacturing of patented international products and reverse-engineering generic drugs, the Indian pharmaceutical industry has turned the country into the 'pharmacy of the world.'

GSK, A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate, US National library of Medicine, Clinical Trials.gov, Posted 13 April 2018

Nagpal J, Choudhury P. Iron formulations in pediatric practice. Indian Pediatr 2004;41(8):807–815

Full Text: PDF

Article Level Metrics

Previous Years | Current Year